Retatrutide 20mg

Commonly researched for: A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors, currently in advanced clinical trials for obesity and metabolic disorders.

• Studied for its effects on appetite regulation
• Researched for insulin sensitivity pathways
• Explored for effects on lipid metabolism

Disclaimer: This product is supplied by Boost Lab Australia for laboratory and research use only. It is not approved by the Therapeutic Goods Administration (TGA) for human or veterinary use, and nothing on this page constitutes medical advice or dosing guidance for use in humans or animals. All research peptides are independently third-party tested to verify composition and purity prior to sale.